Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
PreveCeutical Medical Inc. (PRVCF) had Debt to Capital Ratio of -0.01 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-0.86M |
|
-- |
|
-- |
|
$0.59M |
|
$-0.59M |
|
$-0.26M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.59M |
|
$-0.59M |
|
536.11M |
|
536.11M |
|
$-0.00 |
|
$-0.00 |
|
| Balance Sheet Financials | |
$0.09M |
|
$0.00M |
|
$0.08M |
|
$0.16M |
|
$4.96M |
|
$0.05M |
|
$0.05M |
|
$5.01M |
|
$-4.84M |
|
$-4.92M |
|
$-4.84M |
|
543.70M |
|
| Cash Flow Statement Financials | |
$-0.31M |
|
$-0.00M |
|
$0.36M |
|
$0.00M |
|
$0.04M |
|
$0.04M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-0.01 |
-0.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
17.70% |
|
17.42% |
|
-520.55% |
|
17.87% |
|
$-0.01 |
|
$-0.00 |
|
$-0.00 |
|